In general, G-CSF may be used to prevent the occurrence of severe neutropenia and febrile neutropenia, but the use of prophylactic G-CSF is limited due to a short half-life of 3-4 hours. The gene discussed is CSF3; the disease is Decreased total neutrophil count.